I would say TKRN should be next IMO.I mean they keep buying the world out?LMAO.Read all their PRs.
From AUto, to gold, to bio, to oils,Software.Name it.
Man oh man.Unreal.
Tekron Inc. Announces the Military Applications of the Technology Platform of Biovirus Medical
Thursday November 20, 6:30 am ET
FT. LAUDERDALE, Fla., Nov. 20, 2003 (PRIMEZONE) -- Tekron, Inc. (OTC BB:TKRN.OB - News) announces that Biovirus and Dr. Insell are proceeding with the development of military applications of their combined technology platforms.
Tekron Inc. Announces the Application of the Biovirus Technology Platform to SARS
Thursday November 20, 6:30 am ET
FT. LAUDERDALE, Fla., November 20, 2003 (PRIMEZONE) -- Tekron, Inc. (OTC BB:TKRN.OB - News) announces that in light of the current SARS concern in China, Biovirus is proceeding to immediately develop a putative vaccine for SARS using its mathematical (computational genomics) technology platform. It will use either private financing or apply for a grant with the Canadian Federal government.
Tekron Inc. Announces the Military Applications of the Technology Platform of Biovirus Medical
Tuesday November 18, 8:20 am ET
FT. LAUDERDALE, Fla., Nov. 18, 2003 (PRIMEZONE) -- Tekron, Inc. (OTC BB:TKRN.OB - News) announces that Biovirus and Dr. Insell are proceeding with the development of military applications of their combined technology platforms.
Tekron, Inc. Announces Partnering of the Technology of Biovirus to Advance the Genomic Computational Analysis Platform
Thursday November 13, 6:30 am ET
FT. LAUDERDALE, Fla., Nov. 13, 2003 (PRIMEZONE) -- Tekron, Inc. (OTC BB:TKRN.OB - News) is proceeding to partner and negotiate licensing for the products and technology platform of Biovirus. Biovirus is using its proprietary mathematical technology platform and immunologic expertise to build a library of novel, synthetic antigens because it believes that such antigens will be the key active component(s) of future preventative and therapeutic vaccine products. Biovirus is further committed to partnering with innovative developers and marketers of pharmaceutical and diagnostic products with the goal of making its products available to patients around the world. The Company's principal offices are located in Reno, Nevada.
Tekron, Inc. Announces Application for a $30 million grant to Advance Herpetic Vaccines Against Herpes Simplex I and II, Marak's Disease, SARS and West Nile Virus
Tuesday November 11, 6:30 am ET
FT. LAUDERDALE, Fla., Nov. 11, 2003 (PRIMEZONE) -- Tekron, Inc. (OTC BB:TKRN.OB - News) is undertaking its due diligence of Biovirus, which is proceeding forthwith. It is expected that the deal with Biovirus will close within 30 days without any foreseeable problems. Hence, it has commenced applying for a large $30 million grant over 3 years for the Canadian subsidiary of Biovirus of which Tekron will hold a 50% interest. This funding will be used to advance its research in Herpes Simplex Type 2 (genital herpes),
Tekron, Inc. Announces Entrance into $300 Million Annual Market with the Acquisition of a Minority Interest -- 25% -- of Biovirus, which has Developed a Herpetic Vaccine Against Herpes Simplex I and II
Wednesday November 5, 7:00 am ET
FT. LAUDERDALE, Fla., Nov. 5, 2003 (PRIMEZONE) -- Tekron, Inc. (OTC BB:TKRN.OB - News) has inked an agreement with Biovirus, a privately held biotechnology company that has developed both a prophylactic vaccine and a therapeutic treatment for Herpes Simplex I and II, the primary causative agents for recurring facial and genital lesions said Dr. James Insell, CEO and Chief Scientific Officer for Tekron.
Tekron, Inc. Announces the Acquisition of a Minority Interest (25%) of Biovirus, Which Has Developed a Herpetic Vaccine Against Herpes Simplex I and II
Tuesday November 4, 6:30 am ET
FT. LAUDERDALE, Fla., Nov. 4, 2003 (PRIMEZONE) -- Tekron, Inc. (OTC BB:TKRN.OB - News) has inked an agreement with Biovirus, a privately held biotechnology company that has developed both a prophylactic vaccine and a therapeutic treatment for Herpes Simplex I and II, the primary causative agents for recurring facial and genital lesions said Dr. James Insell, CEO and Chief Scientific Officer for Tekron.
Digital Compression Technology Offered By Tekron Enhances Existing Discs Storage And Internet Transmission Rates
Tuesday October 7, 2003 11:00 am ET
FORT LAUDERDALE, Fla., Oct. 6, 2003 (PRIMEZONE) -- Tekron, Inc. (OTC BB:TKRN.OB - News), tekron-inc.com, today announced the introduction of Tekron Digital Compression Software (TDCS) to the retail market. Tekron's revolutionary new software is capable of compressing data and digital photos up to 1,000 times, thus achieving faster internet transmission speeds than are currently possible. Digital photos retain their original resolution after they are received and decompressed. This process involving JPEG compression, greatly reduces the time required to send files and pictures over the internet and provides approximately 1,000 times more storage space on music, camera video cards & discs for storage of music, video movies, files and pictures for any disc including the small camera discs that are inserted into video and still digital cameras plus 1,000 times faster transmission of video and pictures over the internet
Acquisition of Canachina Inc. Announced by Tekron Inc; Digital Video Broadcasting Compression Technology to be Marketed by Tekron, Inc. in China and North America
Tuesday September 30, 2003 8:00 am ET
FORT LAUDERDALE, Fla., Sept. 30, 2003 (PRIMEZONE) -- Tekron, Inc. (OTC BB:TKRN.OB - News), tekron-inc.com, today announced that the Company will acquire Canachina Inc, a manufacturer of TV, digital set-top receivers and user application software.
Bioremediation and Environmental Engineering Services Launched By Tekron, Inc.
Thursday September 25, 2003 8:00 am ET
FORT LAUDERDALE, Fla., Sept. 25, 2003 (PRIMEZONE) -- Tekron, Inc. (OTC BB:TKRN.OB - News), tekron-inc.com, today announced that the Company will begin services to execute project activities in bioremediation and environmental engineering services for private and public clients.
Tekron, Inc. Announces Agreement to Purchase Substantial Stake in Three Exploration Properties
Monday July 28, 2003 1:18 pm ET
FORT LAUDERDALE, Fla., July 28, 2003 (PRIMEZONE) -- Tekron, Inc. (OTC BB:TKRN.OB - News) announced that pending shareholder approval at the Company's annual meeting August 11, 2003, it has agreed to purchase with Tekron, Inc. shares, an interest in three exploration properties located in Northern Ontario, Canada. Under the agreement, Tekron, Inc. has agreed to keep the three properties held within a Canadian subsidiary in order to capture the beneficial tax treatment via ``flow-through'' funding. The first property, named the Delhi Project in which Tekron, Inc. will have a 50% interest, is located approximately 35 miles from Sudbury, Canada
FORT LAUDERDALE, Fla., July 24, 2003 (PRIMEZONE) -- Tekron, Inc. (OTC BB:TKRN.OB - News) announced that following initial due diligence, it has entered into an exclusive and comprehensive Letter of Intent with Mikasoil International to acquire a 25% equity stake of five oilfields within Russia. Under the terms of the agreement, Tekron will have 90 days to complete its due diligence, and then raise US$5 million to fund the initial phase of the project.
FORT LAUDERDALE, Fla., May 14, 2003 (PRIMEZONE) -- Tekron, Inc. (OTC BB:TKRN.OB - News) today announced that it has entered into a Letter of Intent with Jacobson Resonance Enterprises Inc. |
